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ABSTRACT 
Implantation of intraocular lens with Iris-fixation is a safe, efficient and predictable surgical procedure, 
which empowers the refractive surgeon with singular capabilities. Among their advantages are the 
reversibility, preservation of accommodation and a broad spectrum of ametropic correction. This lens also 
appears to be a valid option, with a favorable complication rate, for the treatment of aphakic eyes without 
capsular support. This article is a review of iris-fixated intraocular lenses and considers their principal 
indications, complications, and outcomes. 
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OVERVIEW 
Three types of Phakic intraocular lenses (pIOLs) are 
commonly used: (I) angle-supported anterior chamber 
lenses; (II) posterior chamber lenses; and (III) iris-fixated 
lenses. This review will focus on the latter. Jan Worst 
developed, in 1978, an iris claw intraocular lens (IOL) for 
the correction of aphakia following cataract surgery (1). 
Later, the concept was modified for use in a Phakic eye 
and the ﬁrst iris-ﬁxated pIOL was implanted by Fechner 
and Worst in 1986 (2). Iris-fixated pIOLs have two 
opposed claw haptics that fixate the lens on the iris by 
enclavation of midperipheral iris stroma, where the iris is 
less vascularized and less reactive (3). In 1991, the 
original biconcave Worst myopia claw lens was changed 
into the convex–concave shape. This design decreased 
the potential for complications, improved the optical 
performance and simplified the implantation technique. 
In 1992, the first hyperopia lens model was implanted 
(4). In 1998, the name of the lens changed to Artisan lens 
(Ophtec B.V., Groningen, the Netherlands), Verisyse in 
the US (5). The Artisan iris-fixated lens is a one-piece all 
polymethyl methacrylate (PMMA) IOL. The total length of 
the lens is 8.5 mm with an optic of 5 or 6 mm in 
diameter. Since 1999, the Artisan lens is also available for 
astigmatism correction. In 2003, the foldable iris-ﬁxated 
Artiﬂex pIOL (Ophtec B.V.), Veriflex in the US, became 
available (5). This model was based on the Artisan 
platform, with a flexible, convex-concave, 6 mm silicone 
optic, PMMA haptics and overall length of 8.5 mm (6). 
The added value of the ﬂexible Artiﬂex over the Artisan is 
the small incision through which it can be inserted (3.2 
mm), decreasing surgically induced astigmatism and 
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accelerating visual recovery (5, 6). Since 2009, the 
Artiflex lens is also available in Europe for astigmatism 
correction. Table 1 summarizes iris-fixated pIOLs 
specifications. 
 
Table 1: Available Iris-fixated pIOLs specifications. Adapted from Alio, 
J.L. and Perez-Santonja (7). 







Myopia -1 to -15.5 
Myopia -1 to -23.5 
Hyperopia +1 to +12 
Toric +6 to -23, torus +1 to +7 













Myopia -2 to -14.5 





Ametropias are the most common eye problem in the 
US. Among individuals over age 40, 30.5 million have 
significant myopia and 12 million visually suffer from high 
hyperopia. Other common refractive errors include 
astigmatism and presbyopia (8, 9). Refractive surgery is 
nowadays a valid alternative to treating a broad range of 
refractive errors and, consequently, the number of 
people seeking this care is likely to increase (8, 10). 
Various surgical modalities and techniques exist to treat 
a broad range of refractive errors. Laser corneal 
refractive surgery is effective, safe and has been the 
favored option for refractive surgery over the last decade 
(11). However, restrictions imposed by corneal thickness, 
curvature or pupil size make it inadequate to treat some 
ametropic eyes, particularly those with high refractive 
errors (12, 13). 
Refractive lens exchange with implantation of an 
appropriate posterior chamber IOL can correct the 
ametropia. Though, lensectomy results in a complete loss 
of accommodation for pre-presbyopic patients and 
carries some retinal risks, especially, in patients with high 
myopia (14, 15). Iris-fixated pIOLs increase the 
capabilities of refractive surgery as they have the 
potential to correct any ametropia, including hyperopia 
and astigmatism. Their power does not depend on tissue 
healing, and their effect is reversible. Furthermore, the 
crystalline lens remains intact, and accommodation is 
preserved (15, 16). Some authors have proposed an 
alternative methodology, combining corneal and 
intraocular procedures to improve results in high 
ametropia (17). This approach called bioptics, consists in 
IOL implantation followed by laser corneal refractive 
surgery and offers a different surgical option to correct 
important refractive errors (18). Iris-fixated pIOLs might 
take part in bioptics as well. Phakic IOLs have also been 
proposed as a surgical option to correct astigmatism and 
spherical ametropia in contact lens intolerant 
keratoconus patients (19). As a combined treatment, iris-
fixated pIOLs have a significant role in the management 
of residual spherocylindrical refractive errors, after other 
keratoconus treatment modalities have been used, 
namely, corneal collagen cross-linking (20) or 
intracorneal ring segments (ICRS) (21). 
 
ARTISAN / VERISYSE 
Follow-up of the Artisan pIOL report that correction of 
moderate to high myopia is a stable, predictable and safe 
method, when inclusion criteria for surgery are applied 
(22). Different studies stated that stabilization of the 
postoperative refraction occurs in the early years after 
implantation, the great majority of the eyes achieve a 
refraction within 1.0 D of the intended correction and 
more than 60% of the patients gained two or more 
Snellen lines of corrected distance visual acuity (CDVA). 
Complications are infrequent and rarely cause loss of 
corrected visual acuity (14,23-25). 
High hyperopia is a challenge in refractive surgery. 
Although the predictability of the refractive results 
appears to be lower than those in the correction of 
myopia and astigmatism (as with other surgical 
procedures for hyperopia), Artisan or Artisan toric pIOLs 
can correct moderate to high hyperopia, combined or 
not with astigmatism, with good refractive results. Still, 
its use is restricted by the anterior chamber depth (ACD), 
of paramount importance for moderate and high 
hyperopia, which is typically accompanied by a shallow 
anterior chamber (26,27). The FDA clinical trial set the 
inferior ACD limit of 3.2 mm, although 3.0 mm is the 
value recommended by the manufacturer (14). Table 2 
summarizes the additional inclusion criteria in the study. 
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Table 2. Inclusion Criteria – US FDA Artisan / Verisyse Clinical Trial. 
Adapted From Stulting, R. D., et al. (14) 
Age 21 – 50 
Axial myopia 4.5 D – 22.0 D (Stable manifest refraction) 
Astigmatism ≤ 2.0 D (Spectacle plane) 
ACD ≥ 3.2 mm 
Pupil size ≥ 4.5 mm (Ambient light) 
Endothelial cell count ≥ 2000 cells/mm2 
 
Phakic intraocular lenses are implanted in a relatively 
young population, and the possibility of progressive 
endothelial cell loss over a lifetime is of concern (14). 
Nevertheless, there is strong evidence in the literature, 
that the current Artisan Phakic IOL design is long-term 
stable, and the implanted lens does not continue to 
stress the endothelium (14, 23). Complications are 
uncommon and appear to be related to the learning 
curve, occurring when surgeons are relatively 
inexperienced (14). Glare levels, accessed using a 
validated questionnaire, are low. Moreover, overall 
satisfaction after Artisan pIOL implantation for myopia is 
excellent (28). 
Refractive surgery is controversial in the pediatric 
population. However, it can be useful for cases of 
amblyopia with poor compliance or when conventional 
treatments are unsuccessful, such as high anisometropia 
and reduced compliance owed to social circumstances or 
neurobehavioral disorders (29, 30). Though more robust 
studies are needed, pIOL implantation appears to be an 
effective option in severe cases of anisometropia 
associated to amblyopia in children, in whom 
conventional treatment methods are not adequate and 
laser refractive surgery is not suitable (30) (Figure 1). 
 
ARTIFLEX / VERIFLEX 
Modern refractive surgery’s standard of minimally 
invasive procedures through minor, sutureless wounds, 
lead into the development of foldable lenses. 
 
Figure 1. Artisan / Verisyse Myopia (3). 
 
Small incisions grant faster visual recovery with less 
induced astigmatism (6). As stated before, the Artiflex is 
a foldable version of the Artisan pIOL, with a similar 
design (Figure 2). Outcomes are mostly comparable with 
those of previous Artisan studies (31). Though a higher 
occurrence of pigment precipitates when compared to 
the Artisan lens has been reported, in most cases they 
appear to be transient and without clinical significance 
(6,31). Artiflex pIOL appears to be a useful improvement 
of the Artisan product family with excellent 
predictability, efficacy, and safety, when speciﬁcations of 
the manufacturer are taken into account regarding 
patient selection and postoperative care (6,32). As with 
the Artisan lens, the author´s experience endorse the 
importance of the morphometric study of the anterior 
chamber (AC) during the follow-up period (33). 
 
APHAKIA 
Following cataract surgery, best result is achieved with 
the implantation of an IOL in the capsular bag. However, 
several conditions can lead to aphakia in eyes with 
insufficient or absent capsule support. Among others, 
these include crystalline lens subluxation, IOL dislocation, 
capsular loss during cataract extraction for congenital or 
juvenile cataract, complicated phacoemulsification for 
senile cataract and trauma (34,35). The resulting aphakia 
can be corrected with aphakic spectacles, contact lenses, 
and implantation of aphakic IOLs (35,36.). 
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Figure 2. Artiflex / Veriflex Myopia (3) 
 
Results with spectacles are often poor because of 
prismatic effects, image magnification, aberrations of 
images, a limited vision field, and appearance concerns 
(37). Contact lenses provide better visual results than 
spectacles; yet, they are associated with a higher risk for 
microbial keratitis and corneal erosion (38). 
Options to surgically correct aphakia include 
implantation of a transsclerally sutured posterior 
chamber (PC) IOL (39), angle-supported AC IOL (40), or an 
iris-fixated IOL (41). Angle-supported AC IOLs are rarely 
used because of the high incidence of secondary 
glaucoma, pupil distortion, endothelial cell loss, and IOL 
instability (42). 
Transsclerally sutured PC IOLs preserve the anterior 
chamber anatomy and cause less endothelial damage 
than angle-supported AC IOLs. However, they present a 
high incidence of intraoperative and postoperative 
complications. In addition, the transscleral ﬁxation of a 
PC IOL is a technically challenging procedure, requiring a 
long surgical time and having a steep learning curve 
(42,43). 
Iris-fixated IOLs (view Table 1 for specifications) are easy 
to place, yield favorable visual outcomes and have a 
lower incidence of intraoperative and postoperative 
complications when compared with the previous IOL 
types (14,43,44). Distinct studies report safe 
implantation of these IOLs even in the pediatric 
population (45) (Figure 3). 
 
Figure 3. The Artisan aphakia IOL presents a biconvex design with 
ultraviolet light filtration. The surgeon implants the IOL by placing it on 
the iris, centering on the pupil and clutching a fold of midperipheral iris 
stroma, without interfering with iris vascularization or the trabecular 
meshwork. They are marginally raised above the iris plane, except at 
the ﬁxation points, preventing them from meddling with the normal 
physiology of the iris or angle structures. These IOLs are used to correct 
aphakia (a similar model is used to correct refractive errors) (14,24) 
 
Primary concern with Artisan aphakic iris-fixated IOL 
implantation is corneal endothelial cell loss (33). This 
is of great significance in children, considering their long 
life expectancy (44). Although more prospective studies 
of corneal endothelium outcomes, particularly in the 
young population, are needed, the corneal endothelial 
cell loss seems to be the result of mechanical injury 
during surgery (34). Furthermore, mean corneal 
endothelial cell density (ECD) was comparable to the 
mean normal ECD in the same age group reported in the 
literature (45). Another concern is the potential damage 
to the iris (34). However, the Artisan IOL design provides 
enough clearance between the IOL and the iris, 
preventing the IOL from interfering with the normal 
physiology of the iris, as long as the IOL is properly 
implanted (46). Other infrequent intraoperative and 
postoperative complications reported with these IOLs 
include IOL dislocation, pupillary block glaucoma 
(ensuring a patent iridotomy is present is of paramount 
importance in any iris-fixated pIOL), retinal detachment, 
pupil ovalization, hyphema, and cystoid macular edema 
(23,47). 
Implantation of an Artisan aphakic iris-fixated IOL is 
supported by different studies, which report promising 
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results and excellent safety, efficacy, predictability and 
stability for the correction of aphakia in eyes with 
insufficient capsular support (43,47,48). 
 
CONCLUSION 
Modern iris-fixated intraocular lenses are the result of 
continuing technological evolution over the last 30 years. 
Their implantation appears a safe, predictable and stable 
surgical procedure, which offers a broad range of 
refractive errors correction and reversibility. Aphakia can 
be corrected with a favorable complication rate. 
Although the concern has been raised about corneal 
endothelial loss and a close follow-up is advisable, no 
reliable evidence puts in danger iris-fixated IOL 
implantation, when speciﬁcations of the manufacturer 
are taken into account. Sequential use of pIOLs after 
additional refractive procedures may result in a better 
visual outcome in selected cases. 
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